Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Equity (2020 - 2025)

Legend Biotech filings provide 6 years of Return on Equity readings, the most recent being 0.0% for Q1 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q1 2025 for Legend Biotech, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2025 to a low of 17.11% in Q2 2021.
  • Median Return on Equity over the past 5 years was 0.0% (2023), compared with a mean of 1.23%.
  • Biggest five-year swings in Return on Equity: surged 837bps in 2021 and later changed 0bps in 2023.
  • Legend Biotech's Return on Equity stood at 0.01% in 2021, then increased by 27bps to 0.0% in 2022, then surged by 74bps to 0.0% in 2023, then fell by -12bps to 0.0% in 2024, then soared by 116bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q1 2025), 0.0% (Q4 2024), and 0.0% (Q3 2024) per Business Quant data.